联苯双酯(Biphenyl diester).doc

  1. 1、本文档共9页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
联苯双酯(Biphenyl diester)

联苯双酯(Biphenyl diester) Biphenyl diester medical aircraft Biphenyl diester is a common drug for the treatment of viral hepatitis and drug-induced liver injury causing elevated transaminase. In the past, it has the pharmacological action of protecting liver cells and increasing the detoxification function of liver. In particular, the effect of enzyme reduction is obvious, and the toxicity is low and the side effects are small. Catalog Essential information purpose clinical application Character usage and dosage Indication Therapeutic effect Open Essential information purpose clinical application Character usage and dosage Indication Therapeutic effect Open Essential information Molecular formula: C20H18O10 Structural formula Molecular weight: 418.36 Biphenyl diester; 4,4- two methoxy -5,6,5, 6- two times a two oxygen -2,2- two formic acid methyl ester biphenyl English Name: Bifendatatum; Biphenyldicarboxylate purpose Usage: anti hepatitis medicine, used for chronic persistent hepatitis, chronic active hepatitis: fatty liver and other diseases. Bifendate (biphenyldicarboxylate) is an enzyme reducing drug developed in China. It is an intermediate of the synthesis of schisandrin C. Pharmacological experiment: mice after oral administration can reduce caused by CCl4 serum alanine aminotransferase (ALT) increased; experiments also show that can enhance liver detoxification function, reduce the pathological damage of the liver and promote liver regeneration and protect liver cells, improve liver function. clinical application By comparing the clinical self control and the control group, it can obviously reduce the enzyme action. After 1 months, the ALT decreased greatly, more than 80% of the chronic hepatitis was effective, and the effect of degrading enzyme increased with the prolongation of the treatment course. Doses of 15mg, 3/ days oral, 1 months after the drug is still no downward trend, may increase the dose, until 30mg. The effect of enzyme reduction is better in pa

您可能关注的文档

文档评论(0)

f8r9t5c + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:8000054077000003

1亿VIP精品文档

相关文档